Eurobank 9M 2026 slides: profit surges 14%, NII guidance raised to 9%

Eurobank reported a 14.3% year-over-year increase in adjusted net profit to €1,209 million for the first nine months of 2026. The bank raised its full-year net interest income growth guidance to 9% from 7%. Shares rose 3.05% to $2.03. Key drivers include margin expansion, loan growth, and improving asset quality in Greece, Cyprus, and Bulgaria. The acquisition of Eurolife Life Insurance is expected to boost fee income.

Original reporting
Published Nov 1, 2026, 11:40 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 1, 2026, 11:47 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$EURBF
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

High
01

Why it matters

The earnings beat and guidance lift are fresh primary disclosures that can drive immediate price movement.

02

Market read

Strong earnings and a higher NII outlook provide a clear catalyst for Eurobank's stock, with potential spillover to regional banking peers.

03

What to watch

Potential regulatory or political risks in Greece could temper the upside despite strong numbers.

Relevance 8/10Novelty 8/10Timing: post-market today

Background

Eurobank presented its nine‑month 2026 results, highlighting profit growth, margin expansion, and a strategic acquisition of Eurolife Life Insurance.

Market effects

Improves outlook for Greek banking sector and regional lenders, suggesting credit quality and profitability trends may be better than expected.

Supports bullish bias on Greek and broader Southern European equities.

Limited to regional markets; no direct global macro impact.

Counterpoint

If the guidance raise is already priced in, the stock may face a short-term pullback on profit‑taking.

Key entities

  • Eurobank

    Greek lender reporting 9M 2026 results.

  • Eurolife Life Insurance

    Acquired by Eurobank to boost fee income.

Related articles

HighAI 8/10

Eurobank builds on its Cyprus presence as group earnings climb

Eurobank reported a €1.16bn net profit for the first nine months of 2026, with its Cyprus operations contributing €367m. The bank's international revenue reached €1.23bn, with Cyprus being the largest contributor. Operating expenses and impairment losses were also detailed. The group's balance sheet expanded, and an interim dividend was declared. Eurobank also provided macroeconomic assumptions for Cyprus, projecting GDP growth and other key indicators.

MedAI 9/10

Eurobank completes Eurolife Life acquisition

Eurobank has finalized the acquisition of an 80% stake in Eurolife Life Insurance from Fairfax Financial Holdings for €813m. The Greek bank now fully owns Eurolife Life. Eurobank also reported a 14.3% rise in adjusted net profit to €1.21bn for the first nine months of 2026, with core income up 9.7% to €2.70bn. The bank announced an interim dividend of €0.0599 per share.

MedAI 8/10

Key facts: EUROBANK S.A. 9M Net €1.16B; NPE 2.4%, Div €0.0599

EUROBANK S.A. reported a 9-month net profit of €1.16B, up 12.4% YoY. Net interest income rose 8.7% to €2.06B, and fees increased 13% to €630M. Loans grew 10.5% to €3.8B. The NPE ratio improved to 2.4%, and an interim dividend of €0.0599 per share will be paid on November 26, according to Reuters.

Med

Morgan Stanley sees upside for Alpha Bank and Eurobank

Morgan Stanley reiterated its positive outlook on Greek banks, with Alpha Bank and Eurobank as top picks. It expects Q3 results to meet market expectations, with net interest income slightly above forecasts. For 2027-2028, it forecasts higher net interest income, potentially leading to upward EPS revisions. Price targets: Alpha Bank €5.50 (28.9% upside), Eurobank €5.40 (21.6% upside).